What’s New in Understanding Scarring Alopecias
Scarring alopecias can be especially distressing for a patient and challenging for a clinician to treat. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Susan C. Taylor, Bernett Johnson Endowed Professor of Dermatology at the University of Pennsylvania Perelman School of Medicine. Watch as Dr. Taylor outlines how a deeper understanding of scarring alopecias is impact …
Scarring alopecias can be especially distressing for a patient and challenging for a clinician to treat. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Susan C. Taylor, Bernett Johnson Endowed Professor of Dermatology at the University of Pennsylvania Perelman School of Medicine. Watch as Dr. Taylor outlines how a deeper understanding of scarring alopecias is impact … Continue reading "What’s New in Understanding Scarring Alopecias"







Welcome to The Roadmap Series: Key Learnings by Residency Year. This first installment, PGY-2 Roadmap: What to Expect in Your First Year of Dermatology Residency, is a concise, practical guide to help new dermatology residents navigate the whirlwind of clinics, didactics, procedures, and consults. Inside you’ll find clear expectations from program directors, tips for mastering dermatologic ter …
Sulfur–sulfacetamide is a long-standing topical therapy in dermatology valued for its combined antimicrobial, anti-inflammatory, and keratolytic effects. It is commonly used for several conditions including acne vulgaris, papulopustular rosacea, and seborrheic dermatitis. Although newer targeted therapies are often preferred for rosacea, sulfur–sulfacetamide remains a practical option, especia …
A 35 year old man presents with this lesion shown in the photo on his hand. The patient undergoes a biopsy for confirmation of the diagnosis. What finding is specific for this condition?
A. Wedge-shaped perivascular lymphocytic infiltrate with eosinophils
B. Fibrinoid necrosis and leukocytoclasia
C. Collapsed keratin bundles
D. Peforating elastin, parakeratosis
E. Epithelial cel …
Hidradenitis suppurativa (HS) remains one of the most challenging chronic inflammatory diseases seen in dermatology. At the 2025 Skin Of Color Update conference in New York City, Dr. Tiffany Mayo led a case-based discussion on emerging therapies and management strategies for HS, with an emphasis on patients with skin of color.
HS affects between 0.1-4% of the population and is more common in …